Elevance Health Long-Term Investments 2010-2025 | ELV
Elevance Health long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Elevance Health long-term investments for the quarter ending March 31, 2025 were $11.227B, a 47.86% increase year-over-year.
- Elevance Health long-term investments for 2024 were $10.784B, a 54.43% increase from 2023.
- Elevance Health long-term investments for 2023 were $6.983B, a 8.48% increase from 2022.
- Elevance Health long-term investments for 2022 were $6.437B, a 9.9% increase from 2021.
| Elevance Health Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $10,784 |
| 2023 | $6,983 |
| 2022 | $6,437 |
| 2021 | $5,857 |
| 2020 | $4,847 |
| 2019 | $4,763 |
| 2018 | $4,246 |
| 2017 | $3,938 |
| 2016 | $2,796 |
| 2015 | $2,630 |
| 2014 | $2,232 |
| 2013 | $2,024 |
| 2012 | $1,849 |
| 2011 | $1,379 |
| 2010 | $1,121 |
| 2009 | $1,038 |
| Elevance Health Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-03-31 | $11,227 |
| 2024-12-31 | $10,784 |
| 2024-09-30 | $10,287 |
| 2024-06-30 | $7,659 |
| 2024-03-31 | $7,593 |
| 2023-12-31 | $6,983 |
| 2023-09-30 | $6,934 |
| 2023-06-30 | $6,768 |
| 2023-03-31 | $6,754 |
| 2022-12-31 | $6,437 |
| 2022-09-30 | $6,138 |
| 2022-06-30 | $6,001 |
| 2022-03-31 | $5,961 |
| 2021-12-31 | $5,857 |
| 2021-09-30 | $5,584 |
| 2021-06-30 | $5,498 |
| 2021-03-31 | $5,032 |
| 2020-12-31 | $4,847 |
| 2020-09-30 | $4,728 |
| 2020-06-30 | $4,617 |
| 2020-03-31 | $4,686 |
| 2019-12-31 | $4,763 |
| 2019-09-30 | $4,461 |
| 2019-06-30 | $4,261 |
| 2019-03-31 | $4,235 |
| 2018-12-31 | $4,246 |
| 2018-09-30 | $4,102 |
| 2018-06-30 | $4,016 |
| 2018-03-31 | $3,995 |
| 2017-12-31 | $3,938 |
| 2017-09-30 | $3,008 |
| 2017-06-30 | $2,909 |
| 2017-03-31 | $2,879 |
| 2016-12-31 | $2,796 |
| 2016-09-30 | $2,726 |
| 2016-06-30 | $2,631 |
| 2016-03-31 | $2,616 |
| 2015-12-31 | $2,630 |
| 2015-09-30 | $2,438 |
| 2015-06-30 | $2,449 |
| 2015-03-31 | $2,279 |
| 2014-12-31 | $2,232 |
| 2014-09-30 | $2,225 |
| 2014-06-30 | $2,216 |
| 2014-03-31 | $2,127 |
| 2013-12-31 | $2,024 |
| 2013-09-30 | $1,985 |
| 2013-06-30 | $2,001 |
| 2013-03-31 | $1,981 |
| 2012-12-31 | $1,849 |
| 2012-09-30 | $1,510 |
| 2012-06-30 | $1,467 |
| 2012-03-31 | $1,316 |
| 2011-12-31 | $1,379 |
| 2011-09-30 | $1,301 |
| 2011-06-30 | $1,203 |
| 2011-03-31 | $1,166 |
| 2010-12-31 | $1,121 |
| 2010-09-30 | $1,109 |
| 2010-06-30 | $1,086 |
| 2010-03-31 | $1,064 |
| 2009-12-31 | $1,038 |
| 2009-09-30 | $1,042 |
| 2009-06-30 | $1,018 |
| 2009-03-31 | $13,271 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.468B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| HealthEquity (HQY) | United States | $8.991B | 39.38 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| CareDx (CDNA) | United States | $1.064B | 16.62 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.670B | 10.14 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |